Michelle Fransen Shares A Historical Review on Plasma-Derived Medicinal Products
Michelle Fransen, Director, Lead for Study Management at Plasma Protein Therapeutics Association (PPTA), shared on LinkedIn:
”I am thrilled to share that Dr. Toby Simon and I had our article, “Source plasma apheresis and plasma-derived medicinal products: a historical review” published in the most recent issue Annals of Blood.
This paper, which can be found here, outlines the history of plasmapheresis and PDMP manufacturing which spans more than a century of scientific and clinical innovation.
We believe that understanding this history is more than academic—it underscores how continued innovation, strong regulatory oversight, and a focus on donor health are essential to sustaining a global plasma supply and advancing care for patients with immune deficiencies, coagulation disorders, and other rare diseases.”
Read the full article here.
Article: Source plasma apheresis and plasma-derived medicinal products: a historical review
Authors: Michelle Fransen, Toby Simon
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 30, 2026, 03:59Emil List Larsen: Identifying SERPINC1 Variants and Limitations of Routine Antithrombin Testing
-
Oct 30, 2026, 02:43D Chandra: Reduce the Apixaban Dose for a Patient with VTE and a Creatinine Clearance of 25?
-
Oct 30, 2026, 02:38Spencer Dorn: Why AI Decision Support Must Integrate Local Clinical Context
-
Oct 30, 2026, 02:33Jens Eschen: Randomized Controlled Trial on Acute Aortic Dissection Anticoagulation Strategies
-
Oct 30, 2026, 02:23Mavis Agnes Kisakye: Landmark Study Paves the Way for Standardized Bleeding Disorder Guidelines in Uganda
-
Oct 30, 2026, 02:16Zelalem G. Moges: Recognizing Leech Infestation in Rural Patients with Unexplained Vaginal Bleeding
-
Oct 29, 2026, 23:09Brad Flora: Reaching 15 Gallons of Lifetime Blood Donations
-
Oct 29, 2026, 23:07David McIntosh: Why We Need Thousands of Blood Donations Every Day
-
Oct 29, 2026, 23:07Tamer El-Sayed: Could Anaemia Be an Overlooked Factor in Patients with Intermittent Claudication?